New to Meducation?
Sign up
Already signed up? Log In
view moderators

PulmonaryMedicine

Category

4
1
26

ALK gene rearrangements, ALK inhibitors, and the Lung Cancer Revolution, by Dr. D. Ross Camidge (video)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. D. Ross Camidge, medical oncologist at the University of Colorado, provides an overview of the newly identified ALK gene rearrangements, novel therapy to target this, and the promise of molecular oncology.</span></p>  
Howard (Jack) West, MD
about 10 years ago
3
2
39

ALK gene rearrangements, ALK inhibitors, and the Lung Cancer Revolution, by Dr. D. Ross Camidge (audio)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. D. Ross Camidge, medical oncologist at the University of Colorado, provides an overview of the newly identified ALK gene rearrangements, novel therapy to target this, and the promise of molecular oncology.</span></p>  
Howard (Jack) West, MD
about 10 years ago
6
1
59

Individualizing First Line Therapy for Advanced NSCLC, by Dr. Suresh Ramalingam (video)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Suresh Ramalingam, medical oncologist and leader of the Thoracic Oncology Program at Emory University, reviews the evolution of first line treatment of advanced non-small cell lung cancer to our current tailored approach for optimal outcomes.</span></p>  
Howard (Jack) West, MD
about 10 years ago
5
1
38

Individualizing First Line Therapy for Advanced NSCLC, by Dr. Suresh Ramalingam (audio)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Suresh Ramalingam, medical oncologist and leader of the Thoracic Oncology Program at Emory University, reviews the evolution of first line treatment of advanced non-small cell lung cancer to our current tailored approach for optimal outcomes.</span></p>  
Howard (Jack) West, MD
about 10 years ago
2
1
58

Should Surgery be Considered for Very Limited Small Cell Lung Cancer? (video)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Howard (Jack) West, medical oncologist, President &amp; CEO of GRACE, reviews the debate about whether surgery should have a role in managing early small cell lung cancer (SCLC).</span></p>  
Howard (Jack) West, MD
about 10 years ago
1
1
62

Should Surgery be Considered for Very Limited Small Cell Lung Cancer? (audio)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Howard (Jack) West, medical oncologist, President &amp; CEO of GRACE, reviews the debate about whether surgery should have a role in managing early small cell lung cancer (SCLC).</span></p>  
Howard (Jack) West, MD
about 10 years ago
6
1
17

Expert Round Table on Managing Advanced Non-Small Cell Lung Cancer (NSCLC) in Elderly and Frail Patients (video)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre;">Case discussion with Drs. Paul Hesketh of the Lahey Clinic and Karen Kelly of Kansas University Medical Center, covering question of optimal treatment for patients with advanced NSCLC who are elderly or have a marginal performance status.<br /></span></p>  
Howard (Jack) West, MD
about 10 years ago
5
1
22

Expert Round Table on Managing Advanced Non-Small Cell Lung Cancer (NSCLC) in Elderly and Frail Patients (audio)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre;">Case discussion with Drs. Paul Hesketh of the Lahey Clinic and Karen Kelly of Kansas University Medical Center, covering question of optimal treatment for patients with advanced NSCLC who are elderly or have a marginal performance status.<br /></span></p>  
Howard (Jack) West, MD
about 10 years ago
2
1
30

Expert Round Table with Drs. Hensing and Jackman on Molecular Markers and Sequencing of Therapy for Advanced NSCLC, Case 2 (audio)

<p>Case discussion with Drs. Tom Hensing of in Chicago &amp; David Jackman in Boston, discussing practical issues around molecular marker testing &amp; recommended treatments for first line &amp; maintenance therapy for an ex-smoker with a lung adenocarcinoma.</p>  
Howard (Jack) West, MD
about 10 years ago
1
1
35

Expert Round Table with Drs. Hensing and Jackman on Molecular Markers and Sequencing of Therapy for Advanced NSCLC, Case 2 (video)

<p>Case discussion with Drs. Tom Hensing of in Chicago &amp; David Jackman in Boston, discussing practical issues around molecular marker testing &amp; recommended treatments for first line &amp; maintenance therapy for an ex-smoker with a lung adenocarcinoma.</p>  
Howard (Jack) West, MD
about 10 years ago
9
1
61

Complications of PEEP and Auto-PEEP

Virtually all patients on ventilators are on PEEP.&nbsp; PEEP has several interactions with various organ systems and some can result in profound complications. An understanding of PEEP and auto-PEEP are required before we can understand modes of ventilation like APRV (Bi-Vent)  
Jeffrey S. Guy, MD, FACS
about 10 years ago
1
1
41

Ventilator Associated Pneumonia

A discussion on nosocomial infections and VAP.<br/>  
Jeffrey S. Guy, MD, FACS
about 10 years ago
7
2
67

Focus On: Treatment Options for Pneumothorax

Define the various types of pneumothoraces. Describe the indications for needle aspiration and small-bore catheter placement in the management of pneumothoraces as outlined by the ACCP and BTS. Discuss the controversies surrounding needle aspiration and small-bore catheter placement for management of pneumothoraces. Identify the characteristics of those patients with pneumothoraces unlikely to be successfully treated with needle aspiration and small-bore catheter placement. Identify sub-sets of patients who have had their pneumothoraces successfully treated with needle aspiration and small-bore catheter placement.  
American College Of Emergency Medicine
about 10 years ago
5
2
63

Focus On: Diagnosis of Pulmonary Embolism

With approximately 600,000 cases and 50,000 deaths per year, this condition challenges emergency physicians to be diligent in their patient evaluation and knowledgeable in their interpretation of nonspecific tests.  
American College Of Emergency Medicine
about 10 years ago
1
1
56

Focus On: Acute Chest Syndrome - The Critical Cough

Acute chest syndrome (ACS) is defined as any acute cardiopulmonary symptom accompanied by a new radiographic infiltrate in a patient with sickle cell disease.  
American College Of Emergency Medicine
about 10 years ago
0
2
55

Focus On: Ultrasound Detection of Traumatic Anterior Pneumothorax

Early detection of a pneumothorax may be important in the clinical management of a trauma patient. Supine chest radiographs in the immobilized trauma patient have been shown to be insensitive.  
American College Of Emergency Medicine
about 10 years ago
10
1
79

Focus On: Treatment of Epistaxis

Epistaxis is one of the most common ear, nose, and throat emergencies, with an estimated 60% lifetime incidence rate for an individual person.  
American College Of Emergency Medicine
about 10 years ago
Preview
7
416

DVT and pulmonary embolisms

This 3D medical animation shows a blood clot forming in a lower leg vein, creating a deep vein thrombosis, or DVT. When the thrombus breaks free of the valve, it is called an embolus, and travels toward the heart and lungs. The animation ends by showing the embolus lodging in the lung tissue forming a life-threatening pulmonary embolism (PE).  
Liz Walker
over 10 years ago
Preview 300x246
6
164

Chest x-Ray

Left Sided Pleural effusion. The most common cause of this presentation is malignancy. It is important to consider the source of a possible primary. It may also be necessary to obtain a sample of the effusion fluid to determine whether it is a transudate or an exudate, using Light's criteria as a guide. Exudate contains greater levels of protein than a transudate reflecting it's often inflammatory origin as the blood vessels become 'leaky' to protein molecules. The differential diagnosis for bilateral pleural effusions is different again. Consider 'failure' e.g. heart, renal or hepatic.  
Tim Ritzmann
almost 11 years ago